Healthcare utilization, follow-up of guidelines and practice variation on rhinosinusitis in adults; a health care reimbursement claims study in the Netherlands.
To provide insight into healthcare utilization of rhinosinusitis, compare data with clinical practice guideline recommendations and assess practice variation. Anonymized data from claims reimbursement registries of healthcare insurers were analyzed, from January 1st , 2016 until December 31st , 2016. Secondary and tertiary care in the Netherlands. Patients ≥ 18 years with diagnostic code "sinusitis". Healthcare utilization (prevalence, co-morbidity, diagnostic testing, surgery), costs, comparison with guideline recommendation, practice variation. We identified 56,825 patients, prevalence was 0.4%. Costs were € 45,979,554.- that is 0.2% of total hospital-related care costs (€21,831.3 x 106 ). Most patients were <75 years, with a slight female preponderance. 29% had co-morbidities (usually COPD/asthma). 9% underwent skin prick testing, 61% nasal endoscopy, 2% X-ray and 51% CT. Surgery rate was 16%, mostly in daycare. Nearly all surgical procedures were performed endonasally and concerned the maxillary and/or ethmoid sinus. 7 recommendations (25%), could be (partially) compared to the distribution of claims data. Except for endoscopy, health care utilization patterns were in line with guideline recommendations. We compared results for three geographical regions and found generally corresponding rates of diagnostic testing and surgery. Prevalence was lower than reported previously. Within the boundaries of guideline recommendations, we encountered acceptable variation in healthcare utilization in Dutch hospitals. Health reimbursement claims data can provide insight into healthcare utilization, but they do not allow evaluation of the quality and outcomes of care and therefore results should be interpreted with caution.